Help Others Discover – Click to Share!
Operational pressure is increasing in NHS cancer services. By 2029, the UK is expected to have a 39% shortfall of consultant radiologists and a 19% shortfall of oncology consultants. Only 68% of histopathology tests are delivered within the NHS target timeframe compared to the target of 98%. More than 420,000 scans are already behind target timelines and nearly 90% of cancer centre leaders report treatment delays affecting patient pathways. Research also shows that even a one-month delay in treatment could increase the risk of cancer mortality by around 10%.
Increased referrals, diagnostic delay, MDT pressure, staffing gaps and fragmentation in service delivery are revealing the imperative need for a forward-looking oncology information system that will support integrated, modern, cancer care.
Aligned with the NHS 10-Year Health Plan, healthcare is increasingly shifting toward connected neighbourhood care centres, interoperable digital ecosystems, and virtual ward integration. Modern oncology pathways now require integrated radiology, pathology, genomics, PACS, referrals, survivorship planning, and remote monitoring within one connected infrastructure.
This is where Cellma, an oncology information system supports healthcare organisations with integrated oncology workflows, interoperability, precision oncology readiness, real-time visibility, and connected patient pathways designed for modern NHS cancer services.
Modern oncology depends on faster diagnostics, multidisciplinary collaboration, genomic-driven therapies, precision medicine, and coordinated care across acute, community, and virtual environments.
However, many providers still rely on disconnected pathology systems, imaging platforms, and distorted oncology workflows. These fragmented systems slow treatment decisions, delay diagnoses, increase duplication, and create operational inefficiencies across the cancer pathway.
The King’s Fund identifies major barriers limiting innovation-ready cancer services, including:
Without a connected oncology information system, healthcare organisations struggle to scale innovation, support AI adoption, or maintain efficient oncology workflows.
Cellma, an advanced oncology information system supports complete longitudinal cancer care, from early detection and diagnostics to survivorship planning and recurrence monitoring.
Cellma supports:
Built specifically for modern oncology operations, Cellma enables connected cancer care across hospitals, neighbourhood care centres, community oncology services, and virtual care environments.
One of the biggest challenges in oncology today is fragmented healthcare infrastructure.
Many providers still operate with disconnected:
This creates fragmented processes for both diagnosis and treatment coordination and lack of visibility.
Cellma unifies diagnostics, MDT coordination, treatment workflows, patient records, and oncology operations within one connected ecosystem.
Cellma supports integration across:
This helps providers reduce duplication, accelerate treatment decisions, and support more connected cancer pathways.
MDT meetings remain central to cancer care delivery, but increasing operational pressure is making traditional MDT models harder to sustain.
Healthcare providers continue facing:
Cellma helps simplify MDT coordination through integrated oncology visibility and connected collaboration workflows.
Clinicians can access:
Cellma also supports future-ready MDT optimisation through automated workflow coordination, integrated case visibility, virtual collaboration capabilities, and real-time oncology pathway management.
AI is rapidly reshaping cancer diagnostics, imaging, genomics, and precision medicine. However, disconnected systems often prevent healthcare organisations from scaling AI effectively.
Cellma supports AI-ready oncology infrastructure through connected workflows, interoperable diagnostics integration, and operational visibility across cancer services.
Cellma supports:
By connecting diagnostics, MDT workflows, patient records, and oncology operations into one ecosystem, Cellma helps providers create the operational foundation required for scalable oncology innovation.
Modern oncology services often struggle with disconnected radiology, pathology, genomics, MDT, referral, and EHR systems that slow diagnostics and treatment coordination. Without interoperability, cancer pathways become fragmented, operational visibility decreases, and MDT collaboration becomes more difficult.
Cellma supports:
This enables healthcare professionals to access connected oncology records while supporting faster, more coordinated cancer care delivery.
Modern oncology systems manage highly sensitive patient, diagnostic, and genomics data, making strong security and governance essential.
Cellma supports secure oncology care delivery through:
This helps healthcare organisations maintain secure, compliant, and connected oncology operations across all care settings.
Cancer services remain under pressure due to growing referrals, diagnostic constraints, workforce pressures, MDT burden, and distorted pathways. With disconnected digital systems the provider faces longer cancer pathways, delayed treatment decisions and inefficiencies.
Cellma helps providers:
Digital documentation alone is not enough to power modern oncology. Modern oncology needs connected workflows, integrated diagnostics, interoperable systems, precision medicine ready technology and real-time oncology visibility.
Cellma supports smarter, faster, and more connected cancer care delivery aligned with modern NHS transformation goals.
Book your free Cellma demo today and explore how Cellma can support future connected oncology care.
Recent Blogs
Let’s transform healthcare together. Speak with RioMed for a tailored solution.
An oncology information system is a specialised healthcare platform designed to support cancer care workflows, including diagnostics, MDT coordination, treatment planning, survivorship tracking, and precision oncology. Modern cancer services require connected systems that integrate radiology, pathology, genomics, patient records, and oncology workflows into one interoperable environment. Cellma helps healthcare providers support connected, efficient, and future-ready cancer care delivery.
Cellma supports interoperable oncology care by integrating radiology, PACS, pathology, laboratory systems, genomics platforms, referrals, and patient records within one connected ecosystem. With HL7 and FHIR-ready interoperability, NHS integration capabilities, secure APIs, and real-time oncology visibility, Cellma helps providers reduce fragmented workflows, accelerate treatment coordination, and support connected cancer pathways.
Yes. Cellma supports precision oncology workflows through genomics integration, biomarker-driven treatment coordination, clinical decision support, and future-ready oncology infrastructure. Cellma also supports virtual ward integration, remote monitoring, survivorship pathways, and connected patient engagement to help providers deliver more accessible and coordinated oncology care.
